Abstract
INTRODUCTION
Cancer is a continued threat for humanity on the globe both in advanced countries as well as developing ones. Various anticancer drugs have been approved by FDA for the treatment of different types of cancers. Most of them are structurally based upon heterocyclic ring systems. Oxadiazole ring system is at significant position among heterocycles due its medicinal properties. This ring system exists in the form of structural isomers 1,3,4-oxadiazole, 1,2,4-oxadiazole and 1,2,3-oxadiazole. oxadiazol-2-yl}-methyl]-2-methyl-1H-benzimidazoles has been recently reported as anticancer agents. Among them, compounds 1, 2 & 3 showed moderate to weak activity against Hep3B (human hepatocellular carcinoma), HeLa (human cervical carcinoma) and MCF 7 (human breast adenocarcinoma) cell lines (Table 1) [1] . A series of indole and 1,3,4-oxadiazole hybrid compounds were recently prepared by Hatti and coworkers and were screened against MCF-7, KB, Colo-205, and A-549 cancer cell lines. Among them, compounds 4-8 were found to exhibit significantly higher anticancer activity as compared to the reference drug etoposide ( Table  2) [20] .
5-(3-Indolyl)-2-(substituted)-1,3,4-oxadiazoles were screened for human cancer cell lines and among the compounds, compounds 52, 53 and 54 exhibited potent cytotoxicity (IC 50~1 µM) and selectivity against human cancer cell lines as shown in Table 11 [21] . Tong et al. described the synthesis of compound 55 showed the best activity with EC 50 value of 3.7 µM [22] . Oxadiazole compounds 56 and 57 were appeared as potent members of anticancer family of drugs [23] .
1,2,4-Oxadiazole
There 
1,2,3-Oxadiazole
In contrast to other oxadiazoles, 1,2,3-oxadiazole ring system is unstable. It isomerizes to formyldiazomethane [32, 33] . That's why, it is least studied for its biological activities. 
CONCLUSION
We have summed up recent literature dealing with anticancer behavior of oxadiazole ring system. Keeping in view the focus of article, we have mentioned only the potent anticancer compounds of the family. The data presented in this article is collected from recent publications in well reputed international journals of medicinal and pharmaceutical chemistry. The structural features could be interesting for medicinal chemists in devising anticancer drugs.
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